Back
Janux Therapeutics Stock Price Chart
Sponsored
JANX
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
29
JANX
Janux Therapeutics
Last Price:
$54.19
Seasonality Move:
84.76%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing slight selling pressure.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.23 | Sell |
20-day SMA: | 57.88 | Sell |
50-day SMA: | 54.34 | Buy |
200-day SMA: | 47.11 | Buy |
8-day EMA: | 57.05 | Sell |
20-day EMA: | 56.98 | Sell |
50-day EMA: | 54.29 | Buy |
200-day EMA: | 44.48 | Buy |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.93 | Buy |
Relative Strength Index (14 RSI): | 47.52 | Sell |
Chaikin Money Flow: | -44683 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.81 - 63.21) | Sell |
Bollinger Bands (100): | (42.47 - 56.33) | Buy |
Janux Therapeutics Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 55.17 while JANX 8-day simple moving average is 57.23, which is a Sell signal.
-
The stock price of JANX is 55.17 while Janux Therapeutics 20-day SMA is 57.88, which makes it a Sell.
-
Janux Therapeutics 50-day simple moving average is 54.34 while JANX share price is 55.17, making it a Buy technically.
-
JANX stock price is 55.17 and Janux Therapeutics 200-day simple moving average is 47.11, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
29
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a SellThe current Janux Therapeutics [JANX] share price is $55.17. The Score for JANX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
2.9B
Price in USD:
55.17
Share Volume:
670.3K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
7.79
Sell
29
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 55.17 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 55.17 while JANX 8-day exponential moving average is 57.05, which is a Sell signal.
-
The stock price of JANX is 55.17 while Janux Therapeutics 20-day EMA is 56.98, which makes it a Sell.
-
Janux Therapeutics 50-day exponential moving average is 54.29 while JANX share price is 55.17, making it a Buy technically.
-
JANX stock price is 55.17 and Janux Therapeutics 200-day simple moving average is 44.48, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.97 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is 0.93, suggesting Janux Therapeutics is a Buy
-
Janux Therapeutics Relative Strength Index (RSI) is 47.52, which suggest Janux Therapeutics is oversold
-
The Bollinger Bands (25) for Janux Therapeutics is (48.81 - 63.21), which suggest Janux Therapeutics is a Buy
-
The Bollinger Bands (100) for Janux Therapeutics is (42.47 - 56.33), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.